Literature DB >> 27572450

Pathogenesis: Infections causing gastric cancer.

Paul Farrell1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27572450     DOI： 10.1038/nmicrobiol.2016.38

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN： 2058-5276            Impact factor:   17.745


× No keyword cloud information.
  10 in total

1.  Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells.

Authors:  Zhen Lin; Kenneth Swan; Xin Zhang; Subing Cao; Zoe Brett; Stacy Drury; Michael J Strong; Claire Fewell; Adriane Puetter; Xia Wang; MaryBeth Ferris; Deborah E Sullivan; Li Li; Erik K Flemington
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

2.  Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells.

Authors:  Chi Man Tsang; Yim Ling Yip; Kwok Wai Lo; Wen Deng; Ka Fai To; Pok Man Hau; Victoria Ming Yi Lau; Kenzo Takada; Vivian Wai Yan Lui; Maria Li Lung; Honglin Chen; Musheng Zeng; Jaap Michiel Middeldorp; Annie Lai-Man Cheung; Sai Wah Tsao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-16       Impact factor: 11.205

3.  The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo.

Authors:  Jin Qiu; Pamela Smith; Leah Leahy; David A Thorley-Lawson
Journal:  PLoS Pathog       Date:  2015-01-15       Impact factor: 6.823

4.  Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.

Authors:  Keisuke Matsusaka; Atsushi Kaneda; Genta Nagae; Tetsuo Ushiku; Yasuko Kikuchi; Rumi Hino; Hiroshi Uozaki; Yasuyuki Seto; Kenzo Takada; Hiroyuki Aburatani; Masashi Fukayama
Journal:  Cancer Res       Date:  2011-10-11       Impact factor: 12.701

5.  Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection.

Authors:  A M Ekström; M Held; L E Hansson; L Engstrand; O Nyrén
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

6.  Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus.

Authors:  Priya Saju; Naoko Murata-Kamiya; Takeru Hayashi; Yoshie Senda; Lisa Nagase; Saori Noda; Keisuke Matsusaka; Sayaka Funata; Akiko Kunita; Masayuki Urabe; Yasuyuki Seto; Masashi Fukayama; Atsushi Kaneda; Masanori Hatakeyama
Journal:  Nat Microbiol       Date:  2016-03-14       Impact factor: 17.745

7.  Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection.

Authors:  Abhik Saha; Hem C Jha; Santosh K Upadhyay; Erle S Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

Review 8.  Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis.

Authors:  Masanori Hatakeyama
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

9.  Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization.

Authors:  Kasper D Hansen; Sarven Sabunciyan; Ben Langmead; Noemi Nagy; Rebecca Curley; Georg Klein; Eva Klein; Daniel Salamon; Andrew P Feinberg
Journal:  Genome Res       Date:  2013-09-25       Impact factor: 9.043

10.  Comprehensive molecular characterization of gastric adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-23       Impact factor: 49.962
  10 in total
  4 in total

1.  Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides.

Authors:  Menghua Xiong; Yan Bao; Xin Xu; Hua Wang; Zhiyuan Han; Zhiyu Wang; Yeqing Liu; Songyin Huang; Ziyuan Song; Jinjing Chen; Richard M Peek; Lichen Yin; Lin-Feng Chen; Jianjun Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-13       Impact factor: 11.205

Review 2.  Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options.

Authors:  Valli De Re; Giulia Brisotto; Ombretta Repetto; Mariangela De Zorzi; Laura Caggiari; Stefania Zanussi; Lara Alessandrini; Vincenzo Canzonieri; Gianmaria Miolo; Fabio Puglisi; Claudio Belluco; Agostino Steffan; Renato Cannizzaro
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

3.  In vivo activation of pH-responsive oxidase-like graphitic nanozymes for selective killing of Helicobacter pylori.

Authors:  Lufeng Zhang; Liang Zhang; Hui Deng; Huan Li; Wentao Tang; Luyao Guan; Ye Qiu; Michael J Donovan; Zhuo Chen; Weihong Tan
Journal:  Nat Commun       Date:  2021-03-31       Impact factor: 14.919

4.  miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9 in H. pylori gastric cancer models.

Authors:  Xuan Liu; Qing Ji; Chengcheng Zhang; Xiaowei Liu; Yanna Liu; Ningning Liu; Hua Sui; Lihong Zhou; Songpo Wang; Qi Li
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.